ACSL4 and pancreatitis: Recent studies have highlighted the suppression of ferroptosis as a potential therapeutic strategy for pancreatitis, possibly through enhancing antioxidant enzymes such as GPX4, promoting iron efflux or sequestration, and reducing pro-ferroptotic proteins like ACSL4.